ORGANON & CO (OGN) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:OGN - US68622V1061 - Common Stock
7.005 USD
-0.2 (-2.71%)
ChartMill assigns a Buy % Consensus number of 48% to OGN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.86. This target is 40.76% above the current price.
OGN was analyzed by 15 analysts. The buy percentage consensus is at 48. So analysts seem to be rather neutral about OGN.
In the previous month the buy percentage consensus was at a similar level.
OGN was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-11 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-11-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-15 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2025-05-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-04-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-02-14 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2024-09-06 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2024-05-06 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-05-03 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2024-04-29 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-02-20 | Goldman Sachs | Maintains | Neutral -> Neutral |
| 2023-11-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-11-03 | Goldman Sachs | Downgrade | Buy -> Neutral |
| 2023-10-25 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-10-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-09-21 | Barclays | Initiate | Overweight |
| 2023-08-09 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-03-16 | Raymond James | Initiate | Outperform |
| 2022-11-04 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-10-14 | B of A Securities | Downgrade | Neutral -> Underperform |
| 2022-10-12 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-09-06 | Piper Sandler | Upgrade | Neutral -> Overweight |
| 2022-08-05 | B of A Securities | Downgrade | Buy -> Neutral |
| 2022-07-08 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-04-27 | Goldman Sachs | Initiate | Buy |
| 2022-02-22 | Morgan Stanley | Maintains | Equal-Weight |
| 2021-10-07 | Piper Sandler | Initiate | Neutral |
| 2021-09-01 | B of A Securities | Initiate | Buy |
ORGANON & CO / OGN FAQ
Can you provide the average price target for ORGANON & CO stock?
15 analysts have analysed OGN and the average price target is 9.86 USD. This implies a price increase of 40.76% is expected in the next year compared to the current price of 7.005.
How do analysts rate ORGANON & CO (OGN)?
The consensus rating for ORGANON & CO (OGN) is 48 / 100 . This indicates that analysts generally have a neutral outlook on the stock.